Abstract: Compositions containing ?2 adrenergic agonists in combination with carbonates and carbamates of the formula. and in combination with related steroid carbonates and carbamates are disclosed. The compositions are useful for treating bronchospasm, for inducing bronchodilation and for treating rhinitis, asthma, and chronic obstructive pulmonary disease (COPD) and inflammatory diseases, particularly by inhalation.

Abstract: A communication apparatus (10) has an antenna (12) suitable for transmitting and receiving signals in a near-field communication (NFC) frequency band. A resonant network is connected to the antenna (12), which is configured to adjust a self resonant frequency of the antenna (12) such that a signal in an FM frequency band may be transmitted or received by the antenna (12). An integrated circuit may be provided with the communication apparatus (10).

Abstract: Apparatus for controlling the generation of a DC signal at the output of a mixer, so that the DC signal is predictable, enabling a static offset compensation voltage to offset the DC signal. The apparatus comprises a mixer configured to receive a first and a second input signal, the mixer being such as to generate a first DC signal at the output of the mixer when the first and second input signal have the same frequency and a first relative phase, a phase detector for determining the relative phase of the first and second signals, and a phase modifier configured to modify the phase of the second signal relative to the first signal in dependence on the determination of the relative phase between the first and second signals such that the resulting DC signal at the output of the mixer is the first DC signal.

Abstract: An inner sleeve having an interior chamber comprised of a bottom panel (12), a top panel (14), a pair of side panels (16,18) and a sealed front end formed by a pair of front closure panels (28, 30) and a pair of front closure flaps (32, 34). A locking flap (36) extends from the opposite end of the bottom panel and can be folded back over the bottom panel such that it will catch when inserted into an outer sleeve. An internal glue flap forms a barrier preventing contents inserted into the inner sleeve from inadvertently slipping out the rear end. A retaining flap (26) extends from the opposite end of the top panel and can be folded inward to create a one way gate that allows a blister pack to be inserted into the interior chamber without allowing it to be withdrawn.

Abstract: A packaging blank includes a first panel and a second panel. The first panel defines at least one blister aperture and at least one tool portion. The second panel defines at least one tab strip and at least one tool access portion. The at least one tab strip is at least partially severable from the packaging blank. The at least one tool access portion is substantially completely severable from the packaging blank. The first panel and the second panel are configured to be positioned relative to one another in a face contacting arrangement such that a first portion of a given tool portion is to be operably aligned with a corresponding tool access portion. As such, the first portion of the given tool portion thereby is capable of being accessed by a tool via the corresponding tool access portion.

Abstract: A packaging blank includes a first panel and a second panel. The first panel defines at least one blister aperture and at least one tool portion. The second panel defines at least one tab strip and at least one tool access portion. The at least one tab strip is at least partially severable from the packaging blank. The at least one tool access portion is substantially completely severable from the packaging blank. The first panel and the second panel are configured to be positioned relative to one another in a face contacting arrangement such that a first portion of a given tool portion is to be operably aligned with a corresponding tool access portion. As such, the first portion of the given tool portion thereby is capable of being accessed by a tool via the corresponding tool access portion.

Abstract: Compositions containing ?2 adrenergic agonists in combination with carbonates and carbamates of the formula. and in combination with related steroid carbonates and carbamates are disclosed. The compositions are useful for treating bronchospasm, for inducing bronchodilation and for treating rhinitis, asthma, and chronic obstructive pulmonary disease (COPD) and inflammatory diseases, particularly by inhalation.

Abstract: The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases.

Abstract: A disclosed entryway lighting system generally includes (a) a door assembly comprising a frame; (b) one or more high-intensity light fixtures mounted within the frame; (c) a power supply electrically connected in a circuit to the light fixtures; (d) a temperature sensor; and, (e) an electrical switch coupled to the temperature sensor and electrically connected to the circuit, the electrical switch having a cut-off temperature above which the light fixtures are turned off. The lighting system improves the visibility, aesthetic appearance, and security of a door mounted in the door assembly. The combination of the temperature sensor and the electrical switch provides an element of safety against excess heat generation and build-up that can result from the use of high-intensity lights.

Abstract: Compositions containing ?2 adrenergic agonists in combination with carbonates and carbonates of the formula and in combination with related steroid carbonates and carbonates are disclosed. The compositions are useful for treating bronchospasm, for inducing bronchodilator and for treating rhinitis, asthma, and chronic obstructive pulmonary disease (COPD) and inflammatory diseases, particularly by inhalation.

Abstract: Compositions containing ?2 adrenergic agonists in combination with carbonates and carbamates of the formula and in combination with related steroid carbonates and carbamates are disclosed. The compositions are useful for treating bronchospasm, for inducing bronchodilation and for treating rhinitis, asthma, and chronic obstructive pulmonary disease (COPD) and inflammatory diseases, particularly by inhalation.

Abstract: The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds of Formula II in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases. wherein X is S, N, O or CR; Y is CRR?, O, NR6, CRR?—CRR? or CR?CR; Z is NR6, O, S, CRR? or CRR?—CRR?; R1-R3 are independently selected from the group consisting of H, C1-C8 alkyl, C1-C8 alkoxy, amino, hydroxy, halosubstituted alky and halo; R4 is Q is CR, NR6 or R5 is H or benzyl; R6 is H, C1-C8 alkyl, C1-C8 alkoxy, OH or halo; and R and R? are independently H, C1-C8 alkyl, C1-C8 alkoxy, OH or halo, or a pharmaceutically acceptable salt thereof.

Abstract: Compositions containing ?2 adrenergic agonists in combination with carbonates and carbamates of the formula and in combination with related steroid carbonates and carbamates are disclosed. The compositions are useful for treating bronchospasm, for inducing bronchodilation and for treating rhinitis, asthma, and chronic obstructive pulmonary disease (COPD) and inflammatory diseases, particularly by inhalation.

Abstract: This invention relates to methods for treating asthma or allergy in a mammal by administering a 3-aminosteroid compound to a mammal in need thereof. The 3-aminosteroid compound being capable of down regulating the IL-9 pathway and alleviating asthmatic responses to allergen. Exemplary 3-aminosteroid compounds used in the methods of the invention include compounds having the chemical formula (I), wherein X, R1, R2, R3, and R4 groups are as defined herein. The invention also relates to certain novel compounds of formula (I). Moreover, the invention also provides methods for identifying an immunomodulatory 3-aminosteroid compound.

Abstract: An exemplary blister package includes a blank having a face panel with blister and finger apertures, a center panel with gates and finger tabs, and a back panel with pull tabs and tear strips. A blister pack is positioned between the face panel and center panel so that each blister is positioned within a respective blister aperture. During assembly, the center and back panels are folded such that each gate and tear strip aligns with a respective blister, and each pull tab and finger tab aligns with a respective finger aperture. The respective panels and elements are bonded except for the tear strips and gates. To remove an item from a blister, the pull tab is pressed out of the panel, the tear strip is peeled from the back panel, and pressure is applied to force the item through the backing sheet of the blister pack and the exposed gate.

Abstract: An apparatus is disclosed which may include a base; and a plurality of spring fingers arranged along a length of the base and defining an opening for receiving an edge of a window pane, the spring fingers adapted to provide respective spring forces to bias against the window pane, wherein a first spring finger is disposed on a first side of the opening and a second spring finger, nearest the first spring finger of any spring finger on a second side of the opening, is offset along the length of the base with respect to the first spring finger.

Abstract: A side ingress water supply conduit arrangement for use with a height adjustable riser for a sprinkler head that reduces labor required for installation of the water supply conduit. The housing of a height adjustable riser is modified to include an integrally molded conduit, which delivers pressurized water to the bottom of an adjustable riser housing by introducing the water supply to the housing via the side of the housing. This allows the conduit to be located closer to the surface of the ground by installing conduits in a shallow burial location slightly below the top of the riser housing. Therefore, less earth removal and replacement is required, which reduces the labor necessary to install a sprinkler system. Another embodiment creates a modified conduit or tube shape, such as a “J” that works with the individual components of the adjustable riser as disclosed in my U.S. Pat. No. 6,629,648.

Abstract: This invention relates to methods for treating asthma or allergy in a mammal by administering a 3-aminosteroid compound to a mammal in need thereof. The 3-aminosteroid compound being capable of down regulating the IL-9 pathway and alleviating asthmatic responses to allergen. Exemplary 3-aminosteroid compounds used in the methods of the invention include compounds having the chemical formula (I), wherein X, R1, R2, R3, and R4 groups are as defined herein. The invention also relates to certain novel compounds of formula (I). Moreover, the invention also provides methods for identifying an immunomodulatory 3-aminosteroid compound.

Abstract: A new and distinct Salvia cultivar named ‘CATHEDRAL SKY BLUE’ is disclosed, characterized by having distinctive light lavender flowers, a compact, very well-branched plant habit, shortened panicle and early, flowering. The new variety is a Salvia, normally produced as an outdoor garden or container plant.

Abstract: A new and distinct Salvia cultivar named ‘CATHEDRAL SKY LAVENDER’ is disclosed, characterized by having distinctive lavender flowers, a compact, very well-branched plant habit, and early, flowering. The new variety is a Salvia, normally produced as an outdoor garden or container plant.